1084. Comparative Outcomes Among Patients Receiving Varying Daptomycin Dosing Regimens in Hemodialysis

BACKGROUND: Daptomycin (DAP) has become an appealing treatment option for gram-positive infections, which are common in patients receiving hemodialysis (HD), due to frequent access and manipulation. The approved DAP dosing of 4 to 6 mg/kg every 48 hours (q48h) quickly becomes desynchronized from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Maxwell, Tyler, Orban, James E, Kufel, Wesley D, Destache, Christopher, Williams, Karen S, Velagapudi, Manasa, Brandon Bookstaver, P, Tatem, Luis, McCracken, James A, Carpenter, Bethanne, Sharma, Roopali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644717/
http://dx.doi.org/10.1093/ofid/ofab466.1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644717/
http://dx.doi.org/10.1093/ofid/ofab466.1278

Ejemplares similares